Pneumococcal vaccine AMC scheme waits for companies to hop on board
This article was originally published in Scrip
Executive Summary
A $1.5 billion scheme designed to accelerate access to vaccines against pneumococcal disease in developing countries has officially been launched. Up to 60 of the world's poorest countries are expected to benefit from the scheme with the introduction of the childhood vaccine as early as 2010.